Medifast Stock Forecast, Price & News

Medifast's stock was trading at $70.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MED stock has increased by 146.5% and is now trading at $173.61.
View which stocks have been most impacted by COVID-19.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Medifast.

Medifast is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Medifast.

Medifast Inc (NYSE:MED) announced its quarterly earnings data on Wednesday, August, 5th. The specialty retailer reported $1.96 EPS for the quarter, topping the consensus estimate of $1.84 by $0.12. The specialty retailer earned $220 million during the quarter, compared to the consensus estimate of $194.75 million. Medifast had a return on equity of 68.55% and a net margin of 10.04%.
View Medifast's earnings history.

Medifast declared a quarterly dividend on Thursday, September 10th. Shareholders of record on Tuesday, September 22nd will be given a dividend of $1.13 per share on Friday, November 6th. This represents a $4.52 dividend on an annualized basis and a dividend yield of 2.60%. The ex-dividend date is Monday, September 21st.
View Medifast's dividend history.

4 Wall Street analysts have issued twelve-month price targets for Medifast's stock. Their forecasts range from $90.00 to $220.00. On average, they expect Medifast's stock price to reach $163.33 in the next twelve months. This suggests that the stock has a possible downside of 5.9%.
View analysts' price targets for Medifast.

Medifast saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 962,400 shares, a drop of 25.4% from the August 15th total of 1,290,000 shares. Based on an average daily trading volume, of 279,300 shares, the short-interest ratio is currently 3.4 days. Approximately 8.6% of the shares of the company are sold short.
View Medifast's Short Interest.

Some companies that are related to Medifast include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Prestige Consumer Healthcare (PBH), USANA Health Sciences (USNA), Inter Parfums (IPAR), Revlon (REV), Nature's Sunshine Products (NATR) and Veru (VERU).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), Home Depot (HD), AbbVie (ABBV), Boeing (BA), Johnson & Johnson (JNJ), Intel (INTC), Adobe (ADBE), Cisco Systems (CSCO) and Exxon Mobil (XOM).

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

Medifast's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.33%), Bank of New York Mellon Corp (1.99%), Principal Financial Group Inc. (1.68%), Principal Financial Group Inc. (1.69%), Charles Schwab Investment Management Inc. (0.99%) and Nordea Investment Management AB (0.87%). Company insiders that own Medifast stock include Carl E Sassano, Constance J Hallquist, Daniel R Chard, Jeffrey J Brown, Michael A Hoer, Michael C Macdonald and Scott Schlackman.
View institutional ownership trends for Medifast.

MED stock was sold by a variety of institutional investors in the last quarter, including 13D Management LLC, Federated Hermes Inc., Vanguard Group Inc., Man Group plc, Bank of America Corp DE, Cubist Systematic Strategies LLC, WINTON GROUP Ltd, and Snow Capital Management LP. Company insiders that have sold Medifast company stock in the last year include Michael C Macdonald, and Scott Schlackman.
View insider buying and selling activity for Medifast.

MED stock was acquired by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, Canada Pension Plan Investment Board, Jacobs Levy Equity Management Inc., Principal Financial Group Inc., Principal Financial Group Inc., Nuveen Asset Management LLC, Euclidean Technologies Management LLC, and Mackay Shields LLC. Company insiders that have bought Medifast stock in the last two years include Daniel R Chard, Jeffrey J Brown, and Michael A Hoer.
View insider buying and selling activity for Medifast.

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MED stock can currently be purchased for approximately $173.61.

Medifast has a market capitalization of $2.04 billion and generates $713.67 million in revenue each year. The specialty retailer earns $77.92 million in net income (profit) each year or $5.96 on an earnings per share basis. Medifast employs 420 workers across the globe.

The official website for Medifast is www.medifast1.com.

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]